Fort Washington Investment Advisors Inc. OH lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 2.2% during the 1st quarter, Holdings Channel.com reports. The firm owned 3,872 shares of the medical equipment provider’s stock after selling 88 shares during the quarter. Fort Washington Investment Advisors Inc. OH’s holdings in Intuitive Surgical were worth $1,918,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Castleark Management LLC grew its holdings in Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock worth $47,221,000 after acquiring an additional 2,990 shares during the last quarter. Truist Financial Corp grew its holdings in Intuitive Surgical by 3.0% in the 4th quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider’s stock worth $129,494,000 after acquiring an additional 7,298 shares during the last quarter. FourThought Financial Partners LLC bought a new stake in Intuitive Surgical in the 4th quarter worth $1,158,000. Longbow Finance SA bought a new stake in Intuitive Surgical in the 4th quarter worth $4,431,000. Finally, Blue Trust Inc. grew its holdings in Intuitive Surgical by 19.7% in the 4th quarter. Blue Trust Inc. now owns 4,467 shares of the medical equipment provider’s stock worth $2,332,000 after acquiring an additional 734 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Price Performance
Shares of NASDAQ ISRG opened at $512.18 on Friday. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00. The stock has a market cap of $183.57 billion, a P/E ratio of 79.90, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67. The firm has a 50-day moving average of $526.57 and a 200 day moving average of $538.46.
Analyst Upgrades and Downgrades
ISRG has been the topic of a number of recent analyst reports. Piper Sandler cut their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a report on Wednesday, April 23rd. Evercore ISI cut their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a report on Wednesday, April 23rd. Truist Financial dropped their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. Citigroup reaffirmed a “buy” rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a “buy” rating in a research report on Monday, April 14th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $588.95.
Get Our Latest Analysis on Intuitive Surgical
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president now directly owns 907 shares of the company’s stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Gary Loeb sold 1,700 shares of Intuitive Surgical stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the transaction, the executive vice president now directly owns 2,245 shares of the company’s stock, valued at $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 4,998 shares of company stock valued at $2,611,577 in the last three months. Company insiders own 0.70% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- What Are Growth Stocks and Investing in Them
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- How Technical Indicators Can Help You Find Oversold Stocks
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- Should You Invest in Penny Stocks?
- Higher Gulf Oil Output Puts These Energy Names in Play
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.